公开(公告)号：US20250032516A1

公开(公告)日：2025-01-30

申请号：US18225270

申请日：2023-07-24

Applicant: POVIVA CORP

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K31/00 ,  A61K47/02 ,  A61K47/28 ,  A61K47/44 ,  A61P25/08

Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.

公开(公告)号：US20240009141A1

公开(公告)日：2024-01-11

申请号：US17857991

申请日：2022-07-05

Applicant: POVIVA CORP

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K31/05 ,  A61K47/44 ,  A61K9/00 ,  A61K47/36 ,  A23L33/00 ,  A23L33/105 ,  A23L33/115 ,  A23D9/007

CPC classification number: A61K31/05 ,  A61K47/44 ,  A61K9/0056 ,  A61K47/36 ,  A23L33/40 ,  A23L33/105 ,  A23L33/115 ,  A23D9/007 ,  A23V2002/00

Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.

公开(公告)号：US20210177978A1

公开(公告)日：2021-06-17

申请号：US17186622

申请日：2021-02-26

Applicant: POVIVA CORP.

Inventor： John Docherty ,  Christopher Andrew Bunka ,  Thomas James Ihrke

IPC: A61K47/46 ,  A61K31/352 ,  A61K36/185 ,  A23F3/40 ,  A23L33/105 ,  A61K31/196 ,  A61K31/405 ,  A61K31/167 ,  A61K31/616 ,  A61K31/5415 ,  A61K31/355 ,  A61K36/82 ,  A61K31/465 ,  A61K45/06 ,  A23L33/15 ,  A23L33/10 ,  A61K31/05 ,  A61K47/36

Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents using tapioca starch or related compounds. Lipophilic active agents include cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins.

公开(公告)号：US20210045998A1

公开(公告)日：2021-02-18

申请号：US16980377

申请日：2019-03-14

Applicant: POVIVA CORP.

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K9/00 ,  A61K9/107 ,  A61K31/4468 ,  A61K31/485 ,  A61K31/5386

Abstract: Aspects described herein relate to improved compositions and methods for transdermal and/or dermal delivery of lipophilic active agents, particularly without the need for added penetration enhancers.

公开(公告)号：US20250032518A1

公开(公告)日：2025-01-30

申请号：US18442061

申请日：2024-02-14

Applicant: POVIVA CORP

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K31/00 ,  A61K9/00 ,  A61K9/20

Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.

公开(公告)号：US20240009140A1

公开(公告)日：2024-01-11

申请号：US17857970

申请日：2022-07-05

Applicant: POVIVA CORP

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K31/05 ,  A61K47/44 ,  A61K9/00 ,  A61K47/36 ,  A61K47/28 ,  A23L33/00 ,  A23L33/105 ,  A23L33/115 ,  A23D9/007

CPC classification number: A61K31/05 ,  A61K47/44 ,  A61K9/0056 ,  A61K47/36 ,  A61K47/28 ,  A23L33/40 ,  A23L33/105 ,  A23L33/115 ,  A23D9/007 ,  A23V2002/00

Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.

公开(公告)号：US11666544B1

公开(公告)日：2023-06-06

申请号：US17857985

申请日：2022-07-05

Applicant: POVIVA CORP

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K31/05 ,  A61K9/51 ,  A61K36/28 ,  A61K47/38 ,  A61K47/26 ,  A61K47/69

CPC classification number: A61K31/05 ,  A61K9/5176 ,  A61K36/28 ,  A61K47/26 ,  A61K47/38 ,  A61K47/6923

Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.

公开(公告)号：US11311559B2

公开(公告)日：2022-04-26

申请号：US17234744

申请日：2021-04-19

Applicant: POVIVA CORP.

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K31/536 ,  A61K31/343 ,  A61K31/422 ,  A61K31/40 ,  A61K31/445 ,  A61K47/16 ,  A61K47/46 ,  A61K47/10 ,  A61K47/36 ,  A61K31/635 ,  A61K9/107 ,  A61K31/403 ,  A61K31/496 ,  A61K31/513 ,  A61K31/435 ,  A61K31/427 ,  A61K31/4709 ,  A61K31/497 ,  A61K31/4433 ,  A61K31/4439 ,  A61K31/505 ,  A61K31/165 ,  A61K31/675 ,  A61K31/551 ,  A61K31/7072 ,  A61K47/44 ,  A61K31/575 ,  A61K35/413 ,  A61K31/4418 ,  A61K31/506 ,  A61K31/7064

Abstract: Disclosed herein are methods, compositions and kits for treating a viral infection, for example, COVID-19, MERS and SARS. The disclosed compositions provide for enhanced delivery of the disclosed antiviral agents.

公开(公告)号：US20220054495A1

公开(公告)日：2022-02-24

申请号：US17234744

申请日：2021-04-19

Applicant: POVIVA CORP.

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K31/536 ,  A61K47/46 ,  A61K47/10 ,  A61K47/36 ,  A61K31/343 ,  A61K31/40 ,  A61K31/422 ,  A61K31/445 ,  A61K31/4439 ,  A61K31/505 ,  A61K31/165 ,  A61K31/7064 ,  A61K31/496 ,  A61K31/506

Abstract: Disclosed herein are methods, compositions and kits for treating a viral infection, for example, COVID-19, MERS and SARS. The disclosed compositions provide for enhanced delivery of the disclosed antiviral agents.

公开(公告)号：US12220422B1

公开(公告)日：2025-02-11

申请号：US18442061

申请日：2024-02-14

Applicant: POVIVA CORP

Inventor： John Docherty ,  Christopher Andrew Bunka

IPC: A61K31/00 ,  A61K9/00 ,  A61K9/20

Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.